| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requester: Good Fit; useful in controlling Alternaria populations with established QoI resistance and use is compatible with cultural disease management practices:05/26;
|
| Reasons for need: |
Alternaria and Cercospora. Resistance to QoI fungicides are well documented and spreading across east coast. Alternative premix chemistries from different FRAC groups are needed:05/26;
|
| Requesting State(s): |
GA:Dutta, Bhabesh* ;
|
| PCR Use Pattern: |
Use Elisys; 7-10 fl. oz/A; 3 foliar applications at 7-10 day interval; 7-day PHI;
|
| EPA Default Residue Trials: |
6 10-6 12
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
Key Export Markets: Canada, Mexico & Japan. IR4 is currently generating residue data for Mefentrifluconazole/Broccoli under PR13741 with E/CS work to manage Alternaria leaf spot is completed.
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|